- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 303
TTU’s Innovation Hub spawns 12 businesses
TTU Innovation Hub graduated six companies from its accelerator and helped its wider affiliate community secure a total of $3.5m in grant funding.
Feb 20, 2019Phylagen traces corporates for $14m series A
The environmental microbiome testing kit maker, based on Oregon research, has collected series A capital from investors including Western Digital Capital and 3M Ventures.
Feb 20, 2019Laurentian hires Haché
Robert Haché will end his tenure as vice-president of research and innovation at York University to lead Laurentian University from July.
Feb 20, 2019Jandhyala bids CoMotion farewell
Vikram Jandhyala is standing down as executive director of University of Washington’s CoMotion but will remain with the university in other capacities.
Feb 19, 2019Liverpool universities grasp Sciontec
University of Liverpool, Liverpool John Moores and Liverpool City Council will launch the Sciontec Liverpool fund to drive works for the city’s $2.6bn Knowledge Quarter Liverpool project.
Feb 19, 2019Glycotest captures $3m from Fosun Pharma
The liver disease diagnostics spinout has secured the first tranche of a $10m series A investment by Fosun Pharma initially announced in October 2018.
Feb 19, 2019Maryland mulls $16m Tedco program
State lawmakers are considering plans to fund supports for Maryland’s cybersecurity and life sciences sectors administered by local economic development agency Tedco.
Feb 19, 2019Passage Bio follows $116m series A trajectory
Passage Bio will develop therapies for diseases affecting the central nervous system based on research by James Wilson at Penn, after raising almost $116m in a series A round.
Feb 19, 2019NetScientific to delist from Aim
Commercialisation firm NetScientific will delist from Aim to free up cash for its portfolio companies, having failed to attract concrete offers after putting itself up for an acquisition.
Feb 19, 2019Vor roars to $42m series A
Osage University Partners has contributed to a series A round for Vor Biopharma, an oncology drug developer based on work by Siddhartha Mukherjee at Columbia University.
Feb 18, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


